{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9829716",
  "DateCompleted": {
    "Year": "1999",
    "Month": "01",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1055-9965",
      "JournalIssue": {
        "Volume": "7",
        "Issue": "11",
        "PubDate": {
          "Year": "1998",
          "Month": "Nov"
        }
      },
      "Title": "Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",
      "ISOAbbreviation": "Cancer Epidemiol Biomarkers Prev"
    },
    "ArticleTitle": "Frequency of trisomy 20 in nonmalignant bronchial epithelium from lung cancer patients and cancer-free former uranium miners and smokers.",
    "Pagination": {
      "StartPage": "1051",
      "EndPage": "1054",
      "MedlinePgn": "1051-4"
    },
    "Abstract": {
      "AbstractText": [
        "Lung cancer is the leading cause of cancer-related deaths. The development of sensitive screening methods to identify at-risk individuals before emergence of clinical disease would permit early intervention that could decrease this mortality. Our previous studies have shown that cells with trisomy 7 can be detected in bronchial epithelium from cancer-free smokers and former uranium miners. However, the use of more than one molecular marker could increase the chance of identifying at-risk individuals. Trisomy 20, which is found in 43-57% of non-small cell lung cancers, is a candidate marker. The purpose of the current investigation was to determine the percentage of cells with trisomy 20 in persons with a high risk for lung cancer. Bronchial epithelial cells that had been assayed for trisomy 7 were assayed for trisomy 20 by fluorescence in situ hybridization. Trisomy 20 was detected in bronchial epithelial cells from lung cancer patients and from smokers and ex-uranium miners without lung cancer. In some cases, patients who were negative for trisomy 7 exhibited trisomy 20. Consequently, more people with field cancerization were identified using both markers. However, the two markers combined did not appear to stratify the risk for lung cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185, USA. RNEFT@lrri.org"
          }
        ],
        "LastName": "Neft",
        "ForeName": "R E",
        "Initials": "RE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Crowell",
        "ForeName": "R E",
        "Initials": "RE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gilliland",
        "ForeName": "F D",
        "Initials": "FD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Murphy",
        "ForeName": "M M",
        "Initials": "MM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lane",
        "ForeName": "J L",
        "Initials": "JL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Harms",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Coons",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Heaphy",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Belinsky",
        "ForeName": "S A",
        "Initials": "SA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lechner",
        "ForeName": "J F",
        "Initials": "JF"
      }
    ],
    "GrantList": [
      {
        "GrantID": "5P50-CA58184",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "CA70190",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S.",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Epidemiol Biomarkers Prev",
    "NlmUniqueID": "9200608",
    "ISSNLinking": "1055-9965"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "4OC371KSTK",
      "NameOfSubstance": "Uranium"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "cytology"
      ],
      "DescriptorName": "Bronchi"
    },
    {
      "QualifierName": [
        "genetics",
        "prevention & control"
      ],
      "DescriptorName": "Carcinoma, Non-Small-Cell Lung"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Chromosomes, Human, Pair 20"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "In Situ Hybridization, Fluorescence"
    },
    {
      "QualifierName": [
        "genetics",
        "prevention & control"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mining"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Occupational Exposure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Predictive Value of Tests"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Smoking"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Trisomy"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Uranium"
    }
  ]
}